Xihua News_Media Center_Shanghai Xihua Detection Technology Service Co., Ltd.

搜索

资讯中心

Current location：

Home

News

Xihua News

2023
01-20 

Yi Huang led the team to visit Xihua before the Spring Festival

On January 18, 2023, Yi Huang, deputy secretary of the Zhoupu Town Party Committee, together with the Town Peace Office, Zhoudong Police Station and other departments, went to Xihua to carry out pre-holiday safety and stability investigation and visits

Learn more +

Yi Huang led the team to visit Xihua before the Spring Festival

2022
12-22 

Dr. Shen was invited to participate in the 2022 Pudong International Talent Port Forum

On December 7, 2022, the Pudong International Talent Port Sub-Forum with the theme of ‘Talent chain drives industrial chain and innovation chain, Creating Pudong's ace Card’ was successfully held.

Learn more +

Dr. Shen was invited to participate in the 2022 Pudong International Talent Port Forum

2022
10-27 

The main project of the first phase of Fujian Xixiang production base was officially launched

On October 26, 2022, the main project of the first phase of Fujian Xixiang API and supporting intermediates production base was officially launched in Mingxi, Fujian. Jinsong Xing, Chairman of Shanghai Xihua Scientific Co., Ltd., Ke Zhong, Secretary of Mingxi County Party Committee, Qing Jin, Vice President of Shanghai Construction NO.5 (Group) Co., Ltd. and Eugene Gong, CEO of Shanghai Xihua Pharmaceutical Co., Ltd. / Chairman of Fujian Xixiang Pharmaceutical Co., Ltd. attended the ceremony and delivered speeches. Huawei Chen, Liangfu Chen, Fengyi Chen, Qiang Li, Ting Xu and other county leaders and heads of relevant departments, Shanghai Xihua Scientific Co., Ltd., Shanghai Xihua Pharmaceuticals Co., Ltd., Fujian South Pharmaceutical Co., Ltd., Shanghai Construction NO.5 (Group) Co., Ltd. attended the ceremony.

Learn more +

The main project of the first phase of Fujian Xixiang production base was officially launched

2022
10-24 

The base project of Xihua R&D Headquarters and Industrialization has officially signed

On October 18, 2022, a group of key projects involving multiple high-tech fields held a centralized signing ceremony in Zhoupu Town. Dr. Jinsong Xing, chairman of Xihua, was invited as a representative of the industrial project to complete the on-site signing under the witness of district and town leaders.

Learn more +

The base project of Xihua R&D Headquarters and Industrialization has officially signed

2022
07-14 

Qing Wang visited Xihua for investigation

July 7, 2022 , at about 10 am , Qing Wang, Party Secretary of Zhangjiang Town, and Li Guan, Deputy Mayor of Zhangjiang Town, and several others visited Shanghai Xihua Scientific Co., Ltd. to carry out large-scale investigations named ‘Epidemic, Economy ,Safety’, Xihua General Manager Xiaohang Shen, Executive Vice President Hao Li, Vice President of Operations Lanjin Qu and other representatives accompanied.

Learn more +

Qing Wang visited Xihua for investigation

2022
06-29 

XIHUA holds TCM Groups, Inc. and dedicates to pushing the development of the global pharmaceutical industry

Recently , Xihua have completed the acquisition of TCM Groups, Inc. (‘TCM’), USA. And then, as one of subsidiary of XIHUA ,TCM will continue to provide clinical trial research professional services to global pharmaceutical companies.

Learn more +

XIHUA holds TCM Groups, Inc. and dedicates to pushing the development of the global pharmaceutical industry

2022
03-14 

Fight the epidemic丨Xihua volunteer team rushed to assist the Shanghai nucleic acid testing team

In March 2022, the epidemic broke out suddenly in Shanghai. On the 14th of the same month, Shanghai Xihua Scientific Co., Ltd. (Xihua) urgently convened volunteers to set up a Xihua nucleic acid testing team and set out for front-line support. This expedition is urgent!

Learn more +

Fight the epidemic丨Xihua volunteer team rushed to assist the Shanghai nucleic acid testing team

2021
08-12 

熙华药业推出莫西沙星RC-4杂质的制备分离方案

莫西沙星（moxifloxacin）是一种新型超广谱喹诺酮类抗菌药，对革兰阳性菌、革兰阴性菌、衣原体和支原体均有良好的抗菌活性。因其具有抗菌性强、抗菌谱广、不良反应少等特点，在临床上被广泛应用于治疗金黄色葡萄球菌、流感杆菌、肺炎球菌等引起的获得性肺炎、慢性支气管炎、急性咽炎、急性鼻窦炎以及急性扁桃体炎等。

Learn more +

2021
06-30 

熙华检测探访红色足迹，庆祝中国共产党百年华诞

2021年是中国共产党建党一百周年。中国共产党从一大建党时的50多名党员，发展成为拥有9514.8万名党员的世界上最大的马克思主义执政党。百年风雨、百年历程，中国共产党的历史波澜壮阔，学习宣传党的历史任重道远。

Learn more +

2021
06-04 

熙华药业联合岛津(上海)实验器材有限公司推出Triton X-100的高灵敏度检测方法

Triton X-100是一种非离子型表面活性剂，其化学名称为聚乙二醇辛基苯基醚。作为常用的灭活剂和裂解剂，该试剂大量应用于生物制品，尤其是疫苗、基因-细胞治疗产品的生产中。由于Triton X-100本身具有一定毒性，因此需要在终产品中对其残留量进行检测。中国药典2020版三部对一些生物制品中Triton X-100的残留量做了明确规定，要求小于15.0 μg/mL，但尚未收载统一的检测方法。

Learn more +